Manufacturer record
Geno Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Geno Pharmaceuticals Pvt. Ltd (Goa) were declared Not of Standard Quality between April 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MV115027, Cinnarizine Tablets IP (exp Nov 2028). Lucknow Lab (state lab) found it not of standard quality: Identification - Doesn't conforms to I.P. Listed in the July 2026 alert.
Records by type
2 records linked to Geno Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cinnarizine Tablets IP | Batch MV115027Mfg Dec 2025 · Exp Nov 2028 | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab | Jul 2026 |
| Fusigen Ointment (Sodium Fusidate Ointment BP) | Batch GF568003Mfg Nov 2018 · Exp Apr 2021 | AssayAssay | CDTL MumbaiCDSCO lab | Apr 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.